181 related articles for article (PubMed ID: 10664991)
21. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
Qi CM; Guo XF; Zhang HB; Li B; Jin W; Dai M
Yao Xue Xue Bao; 2002 Jul; 37(7):522-6. PubMed ID: 12914321
[TBL] [Abstract][Full Text] [Related]
22. Receptor targeting agents for imaging inflammation/infection: where are we now?
Signore A; Chianelli M; D'Alessandria C; Annovazzi A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
[TBL] [Abstract][Full Text] [Related]
23. A ticket to ride: peptide radiopharmaceuticals.
Fischman AJ; Babich JW; Strauss HW
J Nucl Med; 1993 Dec; 34(12):2253-63. PubMed ID: 8254420
[TBL] [Abstract][Full Text] [Related]
24. A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits.
Brouwers AH; Laverman P; Boerman OC; Oyen WJ; Barrett JA; Harris TD; Edwards DS; Corstens FH
Nucl Med Commun; 2000 Nov; 21(11):1043-50. PubMed ID: 11192710
[TBL] [Abstract][Full Text] [Related]
25. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
[TBL] [Abstract][Full Text] [Related]
26. The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.
Decristoforo C; Mather SJ
Q J Nucl Med; 2002 Sep; 46(3):195-205. PubMed ID: 12134136
[TBL] [Abstract][Full Text] [Related]
27. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
Koopmans KP; Glaudemans AW
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
[TBL] [Abstract][Full Text] [Related]
28. Radiation dose estimates in Indian adults in normal and pathological conditions due to 99Tcm-labelled radiopharmaceuticals.
Tyagi K; Jain SC; Jain PC
Radiat Prot Dosimetry; 2001; 95(1):37-42. PubMed ID: 11468803
[TBL] [Abstract][Full Text] [Related]
29. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van der Meer JW; Corstens FH
Eur J Nucl Med; 1998 May; 25(5):535-46. PubMed ID: 9575251
[TBL] [Abstract][Full Text] [Related]
30. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.
Tornesello AL; Tornesello ML; Buonaguro FM
Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023
[TBL] [Abstract][Full Text] [Related]
31. Radiopharmaceuticals for the study of inflammatory processes: a review.
Chianelli M; Mather SJ; Martin-Comin J; Signore A
Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection.
Kniess T; Laube M; Wüst F; Pietzsch J
Dalton Trans; 2017 Oct; 46(42):14435-14451. PubMed ID: 28829079
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
34. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Boerman OC; Oyen WJ; Corstens FH
Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
[TBL] [Abstract][Full Text] [Related]
35. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
36. 99Tcm-citrate: a new bone imaging radiopharmaceutical.
Bhatnagar A; Mishra P; Sharma R; Chuttani K; Chakravarty K; Jain CM; Mondal A; Chopra MK; Gupta A
Nucl Med Commun; 1999 Nov; 20(11):1067-76. PubMed ID: 10572918
[TBL] [Abstract][Full Text] [Related]
37. Imaging infection/inflammation in the new millennium.
Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
Eur J Nucl Med; 2001 Feb; 28(2):241-52. PubMed ID: 11303896
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoimaging of experimental arterial and venous thrombi in dogs with 99Tcm-labelled monoclonal anti-activated platelet antibody SZ-51.
Wu J; He G; Wu G; Ruan C
Nucl Med Commun; 1993 Dec; 14(12):1088-92. PubMed ID: 8295765
[TBL] [Abstract][Full Text] [Related]
39. Imaging inflammation with 99Tcm-labeled chemotactic peptides: analogues with reduced neutropenia.
Pollak A; Goodbody AE; Ballinger JR; Duncan GS; Tran LL; Dunn-Dufault R; Meghji K; Lau F; Andrey TW; Boxen I; Sumner-Smith M
Nucl Med Commun; 1996 Feb; 17(2):132-9. PubMed ID: 8778637
[TBL] [Abstract][Full Text] [Related]
40. Imaging infection and inflammation in an African environment: comparison of 99Tcm-HMPAO-labelled leukocytes and 67Ga-citrate.
Bester MJ; Van Heerden PD; Klopper JF; Wasserman HJ; Rubow S; de Klerk F
Nucl Med Commun; 1995 Jul; 16(7):599-607. PubMed ID: 7478399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
